Recombinant adenoviruses expressing TRAIL demonstrate antitumor effects on non-small cell lung cancer (NSCLC). (Q40276197)

19 September 2017

title

Recombinant adenoviruses expressing TRAIL demonstrate antitumor effects on non-small cell lung cancer (NSCLC). (English)

1 reference

19 September 2017

1 reference

Yang F

1

1 reference

19 September 2017

Shi P

2

1 reference

19 September 2017

Xi X

3

1 reference

19 September 2017

Yi S

4

1 reference

19 September 2017

Li H

5

1 reference

19 September 2017

Sun Q

6

1 reference

19 September 2017

Sun M

7

1 reference

19 September 2017

publication date

1 January 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

23

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

191-204

1 reference

The receptor for the cytotoxic ligand TRAIL

19 September 2017

cites work

1 reference

12 December 2020

Position in cell cycle controls the sensitivity of colon cancer cells to nitric oxide-dependent programmed cell death

1 reference

12 December 2020

Retrovirus-mediated transduction of TRAIL and chemotherapeutic agents co-operatively induce apoptotic cell death in both sarcoma and myeloma cells.

1 reference

12 December 2020

Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors

1 reference

12 December 2020

Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes

1 reference

12 December 2020

TRAIL: a molecule with multiple receptors and control mechanisms

1 reference

12 December 2020

Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial

1 reference

12 December 2020

Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA.

1 reference

12 December 2020

Gene therapy for cancer: what have we done and where are we going?

1 reference

12 December 2020

Sensitization of human colon cancer cells to TRAIL-mediated apoptosis

1 reference

12 December 2020

Chemotherapy augments TRAIL-induced apoptosis in breast cell lines

1 reference

12 December 2020

Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human l

1 reference

12 December 2020

Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria

1 reference

12 December 2020

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

12 December 2020

Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21).

1 reference

12 December 2020

Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene

1 reference

12 December 2020

Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells

1 reference

12 December 2020

p53, the cellular gatekeeper for growth and division

1 reference

12 December 2020

The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors

1 reference

12 December 2020

Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.

1 reference

12 December 2020

Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells

1 reference

12 December 2020

Relative resistance of fresh isolates of melanoma to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.

1 reference

12 December 2020

Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression.

1 reference

12 December 2020

Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL.

1 reference

12 December 2020

Ionizing radiation can overcome resistance to TRAIL in TRAIL-resistant cancer cells

1 reference

12 December 2020

Gene therapy of pancreatic cancer with green fluorescent protein and tumor necrosis factor-related apoptosis-inducing ligand fusion gene expression driven by a human telomerase reverse transcriptase promoter

1 reference

12 December 2020

Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.

1 reference

12 December 2020

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

12 December 2020

Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis

1 reference

12 December 2020

Molecular determinants of response to TRAIL in killing of normal and cancer cells.

1 reference

12 December 2020

Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death

1 reference

12 December 2020

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

12 December 2020

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

12 December 2020

1 reference

12 December 2020

An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAIL

1 reference

12 December 2020

Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells

1 reference

12 December 2020

Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types

1 reference

12 December 2020

Identifiers

DOI

10.1385/MO:23:2:191

1 reference

Dimensions Publication ID

19 September 2017

1022338260

0 references

Fatcat ID

release_miim7354ujbtfnasjxekpgnf34

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/miim7354ujbtfnasjxekpgnf34

24 November 2022

mapped directly with Wikidata item

1 reference